4) Helping develop and validate methods to quantify genetic pleiotropy.[20] These genetic pleiotropy methods have provided valuable insights across a number of diseases and identified Novel Single Nucleotide Polymorphisms (SNPs) associated with increased risk for schizophrenia, bipolar disorder,[21] Alzheimer's disease,[22] Parkinson's disease, frontotemporal dementia,[23][24] corticobasal degeneration,[25] hypertension, hypercholesterolemia and coronary artery disease.[26]